ACC/SCAI Premier Interventional Cardiology Overview and Board Preparatory Course

June 12, 2017 — Abiomed Inc. recently released its third-generation Impella CP heart pump at the 2017 meeting of the Society for Cardiovascular and Angiography Interventions (SCAI). The technology offers new features for optimal care during a percutaneous coronary intervention (PCI) in high-risk patients known as a Protected PCI, and for patients being treated with Impella in the intensive care unit (ICU). 

June 12, 2017 – Med Alliance announced completion on schedule of patient enrollment in the first-in-man (FIM) study of SELUTION, a novel sirolimus-coated balloon. The 50 patient study enrolled between October 2016 and May 23, 2017 across four German centers: Franziskus Krankenhaus, Berlin; Evangelisches Krankenhaus Hubertus, Berlin; Vivantes Klinikum Neukölln, Berlin; and Universitäts-Herzzentrum, Bad Krozingen.

June 12, 2017 — TandemLife began its commercial launch of the TandemLife Priming Tray, a new product designed to simplify and speed up the process of putting critically-ill patients on extracorporeal life support, providing healthcare professionals with a vital window of opportunity to accurately assess a patient’s condition and provide appropriate care.

June 12, 2017 — Heart muscle is one of the least renewable tissues in the body, which is one of the reasons that heart disease is the leading cause of death for both men and women in the United States, according to the Centers for Disease Control and Prevention. Inspired by the idea of helping the heart repair itself, researchers at Baylor College of Medicine and the Texas Heart Institute have studied pathways known to be involved in heart cell functions and discovered a previously unknown connection between processes that keep the heart from repairing itself.

June 12, 2017 — A study using strain imaging presented at the American Society of Echocardiography (ASE) 2017 demonstrated increased utility with contrast-enhanced echo studies. Performed by a group from the University of Chicago, the study indicated EchoInsight to be accurate in assessing contrast-enhanced echo with its proprietary software, Epsilon Imaging’s EchoInsight, providing global longitudinal strain (GLS). 

June 12, 2017 – The Medtronic Resolute Onyx Drug-Eluting Stent (DES) met its primary endpoint of target lesion failure (TLF) at one year for the treatment of coronary artery disease in extra-small vessels. Results from the RESOLUTE ONYX 2.0 mm Clinical Study were presented today as a late-breaking trial session at the 2017 EuroPCR annual meeting and simultaneously published in the Journal of the American College of Cardiology (JACC): Cardiovascular Intervention.

Medica and Compmed Medical Technology Conference

World Federation of Nuclear Medicine and Biology

San Diego Cardiovascular Interventions Course

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now